Skip to main content

China

Grandprint (Shengda) adds six HEIDELBERG Speedmaster CX 92 presses to scale China web-to-print packaging output

Image

SHERIDAN, WYOMING - March 17, 2026 - Grandprint (Shengda) has expanded its web-to-print operations by purchasing six additional Speedmaster CX 92 presses from Heidelberger Druckmaschinen AG (HEIDELBERG). The move continues what HEIDELBERG describes as a sustained investment cycle by the printer in digital and hybrid technologies from HEIDELBERG and Gallus. For commercial leaders and production managers, the purchase signals added conventional press capacity aligned with hybrid workflows, aimed at meeting demand patterns tied to packaging and label work in China. It also indicates continued capital deployment into equipment that can support web-to-print-driven order volumes and turnaround expectations.

BMS Signs $1B-Plus Multi-Specific Antibody Pact With China's Harbour BioMed

Image
BMS Signs $1B-Plus Multi-Specific Antibody Pact With China’s Harbour BioMed

SHERIDAN, WYOMING - December 19, 2025 - Bristol Myers Squibb (BMS) has struck a potential $1B-plus partnership with Harbour BioMed to collaborate on next-generation multi-specific antibody programs, underscoring how China-based innovation is increasingly shaping global biologics dealmaking.

Deal scope and economics in brief
BMS will pay $90 million upfront to work with Harbour on developing and advancing multi-specific antibody therapies, with additional development and commercial milestones that could total up to $1.035 billion. The partners did not disclose how many programs are covered, nor did they specify initial targets, indications, or therapeutic areas.

For business development teams and portfolio planners, the structure reflects a familiar "platform-plus-programs" model: BMS buys early discovery leverage and optionality, while Harbour positions itself for milestone upside and downstream royalties if programs progress.

Dubai Airshow 2025 Opens with COMAC C919 Making Middle East Debut as Chinese Aviation Presence Expands

Image
Dubai Airshow 2025 Opens with COMAC C919 Making Middle East Debut as Chinese Aviation Presence Expands

SHERIDAN, WYOMING - December 15, 2025 - Dubai Airshow 2025 opened at Dubai World Central with the Middle East debut of two of China's homegrown C919 aircraft, signaling a higher-profile push by Chinese aerospace players to showcase commercial, unmanned, and next-generation aviation technologies to global buyers.

C919 debut puts China's narrowbody on a new international stage
At the 19th edition of the Dubai Airshow, the appearance of the C919 marked its first showing in the Middle East, with a flight demonstration at the venue. The aircraft's presence matters beyond the air display: for airlines, lessors, MRO providers, and airport stakeholders, international showcases help shape early market perception around supply-chain maturity, support ecosystems, and longer-term export ambitions.

ARIDGE Unveils A868 Tilt-Rotor Hybrid Flying Car as Land Aircraft Carrier Factory Enters Trial Production

Image
ARIDGE Unveils A868 Tilt-Rotor Hybrid Flying Car as Land Aircraft Carrier Factory Enters Trial Production

SHERIDAN, WYOMING - December 15, 2025 - ARIDGE has introduced new details on its next-generation A868 flying car concept and confirmed fresh progress at its flying car manufacturing plant, as the company positions two flight systems to serve different segments of China's emerging low-altitude mobility market.

Two flight systems target distinct low-altitude travel needs
ARIDGE framed the low-altitude economy as the next major growth frontier following new energy vehicles, and outlined a dual-product strategy built around different operating missions. The company is developing:

XPENG AEROHT Starts Trial Production at Flying Car Plant, Marking Shift Toward Scaled eVTOL Manufacturing

Image
XPENG AEROHT Starts Trial Production at Flying Car Plant, Marking Shift Toward Scaled eVTOL Manufacturing

SHERIDAN, WYOMING - December 15, 2025 - XPENG AEROHT, the flying car affiliate of Chinese EV maker XPENG, has begun trial production at what it describes as the world's first intelligent factory for mass-produced flying cars-an operational milestone as next-generation mobility moves from prototypes to industrial output.

Trial production signals a commercialization inflection point
The company started trial production on November 3, 2025, positioning the facility as a bridge between engineering validation and repeatable manufacturing. For the broader eVTOL and "low-altitude mobility" ecosystem, factory readiness matters because it shifts the discussion from flight demonstrations to supply chains, quality systems, and scalable assembly-areas that typically determine whether new vehicle categories can reach customers on schedule.

Shanghai M&A Finance Conference Unveils New Deal Index and Multi-Institution Alliance to Accelerate Listed-Company Transactions

Image
Shanghai M&A Finance Conference Unveils New Deal Index and Multi-Institution Alliance to Accelerate Listed-Company Transactions

SHERIDAN, WYOMING - December 15, 2025 - Shanghai is sharpening its push to become a leading center for merger-and-acquisition activity, as the 2025 Mergers and Acquisitions Finance Conference spotlighted stronger regional deal momentum and unveiled a new market index intended to track China's evolving M&A environment.

Policy momentum behind listed-company restructuring
The conference took place as Shanghai marks one year since releasing a three-year action plan aimed at supporting M&A among listed firms. In practical terms, the message to corporate leaders and capital providers is clear: policy alignment and financial-market infrastructure are being positioned to support more transactions that improve efficiency, accelerate industrial upgrading, and strengthen competitiveness in key sectors.

Pfizer Deepens Cardiometabolic Push with Global YaoPharma Deal for Oral GLP-1 Candidate

Image
Pfizer Deepens Cardiometabolic Push with Global YaoPharma Deal for Oral GLP-1 Candidate

SHERIDAN, WYOMING - December 10, 2025 - Pfizer Inc. is expanding its cardiometabolic ambitions through an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical, to develop, manufacture and commercialize YP05002, an oral GLP-1 receptor agonist currently in Phase 1 for chronic weight management. The deal strengthens Pfizer's position in the fast-moving obesity field and adds a differentiated small-molecule asset to its portfolio of metabolic disease candidates.

Strategic Bet on Small-Molecule GLP-1 in Obesity

Under the agreement, China-based YaoPharma will complete an ongoing Phase 1 study of YP05002 before transferring global development and commercialization rights to Pfizer. For Pfizer, the asset fits neatly into a strategy that aims to pair novel mechanisms with scalable, oral delivery formats for obesity and adjacent cardiometabolic conditions.

Jiangyin Secures 68 Billion RMB in "Golden Autumn" Investments to Power Next-Gen Manufacturing

Image
Jiangyin Secures 68 Billion RMB in “Golden Autumn” Investments to Power Next-Gen Manufacturing

SHERIDAN, WYOMING - December 10, 2025 - Jiangyin, a key industrial hub in China's Yangtze River Delta, has wrapped up its 2025 Golden Autumn Month of Investment with 208 newly signed projects worth a combined 68 billion RMB, underscoring the city's ambitions in integrated circuits, next-generation information technology, advanced manufacturing and clean energy. For global investors and industrial operators, the city is signaling a long-term commitment to high-value, supply-chain-dense clusters backed by capital, research alliances and pro-business policy.

Golden Autumn Campaign Delivers 208 Projects and Deepens 14th FYP Momentum

Philippines E-Visa Rollout in China Targets Faster Growth for Travel Trade Partners

Image
Philippines E-Visa Rollout in China Targets Faster Growth for Travel Trade Partners

SHERIDAN, WYOMING - December 8, 2025 - The Philippines is stepping up its outreach to China's travel industry with a dedicated e-visa training roadshow, as Manila moves to make short-stay tourism and business travel easier and more predictable for Chinese visitors - and to give tour operators, OTAs and consolidators a clear operational playbook ahead of the next wave of demand.

Shenyang Training Puts Front-Line Travel Sellers in Focus

In Shenyang, the Philippine Embassy in China and the Philippine Department of Tourism (PDOT) co-hosted the "菲常旅程,E触即行" e-visa training for the local travel trade, drawing agency representatives and distribution partners from across the region. The session served both as a policy briefing and as a hands-on workshop, designed to ensure that front-line sellers understand eligibility, processes and system workflows.

HEIDELBERG's 1,000th Speedmaster CX 104 Powers Hoifu Group's Push Into China's Premium Packaging Segment

Image
HEIDELBERG’s 1,000th Speedmaster CX 104 Powers Hoifu Group’s Push Into China’s Premium Packaging Segment

SHERIDAN, WYOMING - December 8, 2025 - Heidelberger Druckmaschinen AG (HEIDELBERG) has reached a major milestone with the delivery of its 1,000th Speedmaster CX 104 press, a 14-unit specialty configuration bound for the fast-growing Chinese packaging printer Hoifu Group, underscoring strong demand for high-performance, value-optimized presses in the premium packaging market.

Global Bestseller Targets High-End Packaging Growth in China

The Speedmaster CX 104 has become the bestseller in HEIDELBERG's portfolio thanks to its attractive price-performance ratio and broad suitability for commercial and packaging applications. The landmark 1,000th unit will be installed at Hoifu Group's new site in Yancheng, where it will run as part of an end-to-end, Prinect-based workflow.